A trial date has been set for April 5, 2010, on Forest Laboratories Inc.’s patent infringement complaint against generic manufacturers of Namenda, the Company’s N-methyl-D-aspartate.
During the third quarter of fiscal…
A trial on the patent infringement action captioned Infosint S.A. v. H. Lundbeck A/S, H. Lundbeck Inc. and Forest Laboratories, Inc., is scheduled to begin on Sept. 28, 2009.
In April…
Forest Laboratories Inc. and H. Lundbeck A/S face Caraco Pharmaceutical Laboratories, Ltd.’s declaratory judgment action for non-infringement of a third patent for Lexapro.
Lexapro was developed by the Company and Lundbeck,…
Expert discovery in the consolidated patent infringement action captioned Forest Laboratories, Inc. et al. v. Cobalt Laboratories Inc. et al., is set to end on Sept. 11, 2009.
Beginning in January…
The patent infringement suit captioned Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,
remains pending in the U.S. District Court for the Eastern District of Michigan.
In September…
A trial on Caraco Pharmaceutical Laboratories, Ltd.’s action against Forest Laboratories Inc. and H. Lundbeck A/S seeking a declaratory judgment of non-infringement is scheduled to begin on Oct. 27, 2009.
In…
Discovery is scheduled to continue in Forest Laboratories Inc.’s suit against Caraco Pharmaceutical Laboratories Ltd. for the alleged infringement of U.S. Patent No. Re. 24,712 in the U.S. District Court…
Forest Laboratories Inc.’s patent infringement suit against Caraco Pharmaceutical Laboratories Ltd. over U.S. Patent No. 6,916,941, in the U.S. District Court for the Eastern District of Michigan is in discovery.
On…